GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **751 - 775** of **4050** in total

« First

‹ Prev

…

27

28

29

30

31

32

33

34

35

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgG	Patient 3	-180	mild	G21460SG	46
IgG	Patient 3	-180	mild	G40696TO	46
IgG	Patient 3	-180	mild	G47566FL	46
IgG	Patient 3	-180	mild	G91537AT	46
IgG	Patient 3	-180	mild	G92022ML	46
IgG	Patient 3	11	mild	G00054MO	46
IgG	Patient 3	11	mild	G28868ZC	46
IgG	Patient 3	4	mild	G00065MO	46
IgG	Patient 3	4	mild	G22768VO	46
IgG	Patient 1	22	moderate	G71469XA	47
IgM	Patient 1	10	moderate	G35446HX	47
IgM	Patient 1	10	moderate	G77974XY	47
IgM	Patient 1	22	moderate	G84224TW	47
IgG	Patient 2	15	mild	G16579HJ	47
IgG	Patient 2	15	mild	G36191CD	47
IgG	Patient 2	15	mild	G39213VZ	47
IgG	Patient 2	15	mild	G61751GZ	47
IgM	Patient 1	6	moderate	G00053MO	47
IgM	Patient 1	6	moderate	G22768VO	47
IgG	Patient 2	3	mild	G32699RJ	47
IgM	Patient 2	3	mild	G94435QH	47
IgG	Patient 3	-180	mild	G00052MO	47
IgG	Patient 3	-180	mild	G36544AC	47
IgG	Patient 3	-180	mild	G62826CL	47
IgG	Patient 3	-180	mild	G73271MD	47